Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- SBS.F
- Price
- 23.55
- Stock movement down
- -0.10 (-0.42%)
- Company name
- Stratec SE
- Exchange
- (F ,
- Currency
- EUR )
- Sector
- Healthcare >Medical Devices
- Markedsværdi
- 286.27M
- Ent værdi
- 476.24M
- Pris/omsætning
- 1.14
- Pris/bog
- 1.26
- Udbytte afkast
- -
- Udbyttevækst
- -
- Vekst år
- -
- FCF-udbetaling
- 0.01%
- Efterfølgende P/E
- 28.59
- Fremtidig P/E
- 12.68
- PEG
- -
- EPS-vekst
- 7.48%
- 1 års afkast
- -49.95%
- 3 års afkast
- -35.61%
- 5 års afkast
- -24.17%
- 10 års afkast
- -7.32%
Senest opdateret: 2025-06-22
UDBYTTE
SBS.F betaler ikke udbytte
VÆRDIANSÆTTELSE
Værdiansættelsesforhold
Loading...
Værdiansættelsesforhold-data
| Efterfølgende P/E | 28.59 |
| Pris til OCF | 8.38 |
| Pris til FCF | 15.59 |
| Pris til EBITDA | - |
| EV i forhold til EBITDA | - |
Værdiansættelse (salg/bogført værdi)
Loading...
Værdiansættelse (salg/bogført værdi)-data
| Pris til omsætning | 1.14 |
| Pris til egenkapital | 1.26 |
| EV i forhold til salg | 1.90 |
ØKONOMI
Pr. aktie
Loading...
Data pr. aktie
| Aktuelt antal aktier | 12.16M |
| EPS (TTM) | 0.82 |
| FCF pr. aktie (TTM) | 1.51 |
Resultatopgørelse
Loading...
Resultatopgørelse-data
| Omsætning (TTM) | 250.54M |
| Bruttofortjeneste (TTM) | 67.75M |
| Driftsindkomst (TTM) | 22.09M |
| Nettoindkomst (TTM) | 10.01M |
| EPS (TTM) | 0.82 |
| EPS (1 år frem) | 1.86 |
Marginer
Loading...
Marginer-data
| Bruttomargin (TTM) | 27.04% |
| Driftsmargin (TTM) | 8.82% |
| Fortjenstmargin (TTM) | 4.00% |
Balance
Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Balancedata
| Kontanter | 33.11M |
| Nettotilgodehavender | 38.55M |
| Omsætningsaktiver i alt | 235.49M |
| Goodwill | 50.16M |
| Immaterielle aktiver | 63.37M |
| Ejendomme, anlæg og udstyr | 81.63M |
| Sum aktiver | 450.84M |
| Kreditor | 13.10M |
| Kortfristet/nuværende langsigtet gæld | 0.00 |
| Summen af kortfristede forpligtelser | 93.36M |
| Sum gæld | 223.08M |
| Aktionærernes egenkapital | 227.76M |
| Materielle nettoaktiver | 0.00 |
Likviditet
Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Kontantstrøm-data
| Likviditet fra driften (TTM) | 34.15M |
| Investeringsudgifter (TTM) | 15.78M |
| Fri pengestrøm (TTM) | 18.37M |
| Udbetalt udbytte (TTM) | 1.00K |
Finansiel indkomst
Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Data om finansiel indkomst
| Egenkapitalafkast | 4.40% |
| Afkast af aktiver | 2.22% |
| Afkast af investeret kapital | 4.40% |
| Kontant afkast af investeret kapital | 8.06% |
INFORMATION OM AKTIER
Aktiediagram
Loading...
Aktiekurs-data
| Åbning | 23.60 |
| Daglig høj | 23.60 |
| Daglig lav | 23.55 |
| Daglig volumen | 1K |
| Højeste gennem alle tider | 145.20 |
| 1 års analytiker estimat | 41.00 |
| Beta | 0.23 |
| EPS (TTM) | 0.82 |
| Udbytte pr. aktie | - |
| Ex-div dato | 20 May 2024 |
| Næste dato for resultatpræsentation | 19 Aug 2025 |
Nedsidepotensial
Loading...
Nedsidepotensial-data
| SBS.F | S&P500 | |
| Nuværende prisfald fra top notering | -83.78% | -3.04% |
| Højeste prisfald | -97.63% | -56.47% |
| Højeste efterår dato | 24 Oct 2002 | 9 Mar 2009 |
| Gennemsnitlig fald fra toppen | -61.69% | -11.04% |
| Gennemsnitlig tid til nyt højdepunkt | 257 days | 12 days |
| Maks. tid til nyt højdepunkt | 5158 days | 1805 days |
OPLYSNINGER OM VIRKSOMHEDEN
Markedsværdi
286.27M
Markedsværdi kategori
Small-cap
Beskrivelse
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
Personale
1462
Hjemmeside
Investor relationer
-
SEC-indsendelser
Adm. direktør
Land
Germany
By
Aktietype
-
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRÆSENTATIONER
ArrangementerPræsentationer
Loading...
FORSTÅ FORRETNINGEN
Loading...
NYHEDER OM VIRKSOMHEDEN
Alle nyhederPressemeddelelser
As an investor, mistakes are inevitable. But really big losses can really drag down an overall portfolio. So take a...
22. juni 2025
Despite a revenue dip, Stratec SE (XTER:SBS) boosts margins and cash flow, setting a strong foundation for future growth.
20. maj 2025
Stratec ( ETR:SBS ) Full Year 2024 Results Key Financial Results Revenue: €257.6m (down 1.6% from FY 2023). Net income...
20. maj 2025
As European markets experience a boost, with the pan-European STOXX Europe 600 Index rising 3.44% amid easing tariff concerns, investors are increasingly focused on growth opportunities within the reg...
8. maj 2025
Amidst a backdrop of economic uncertainty and inflationary pressures, European markets have faced challenges with the recent imposition of U.S. trade tariffs impacting investor sentiment. Despite thes...
4. april 2025
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Typically...
25. marts 2025
As the pan-European STOXX Europe 600 Index continues its streak of weekly gains, buoyed by encouraging company results and resilience amidst global trade uncertainties, investors are increasingly focu...
7. marts 2025
As the European market experiences a mixed economic landscape, with the pan-European STOXX Europe 600 Index showing resilience amidst global uncertainties, investors are increasingly focusing on growt...
6. marts 2025
Key Insights Given the large stake in the stock by institutions, Stratec's stock price might be vulnerable to their...
20. februar 2025
As global markets rally with U.S. stocks reaching record highs, driven by optimism around AI advancements and potential trade resolutions, growth stocks have notably outperformed their value counterpa...
31. januar 2025
Næste side